
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Molecular Mechanisms Driving mRNA Degradation by m6A Modification
Yujin Lee, Junho Choe, Ok Hyun Park, et al.
Trends in Genetics (2020) Vol. 36, Iss. 3, pp. 177-188
Open Access | Times Cited: 344
Yujin Lee, Junho Choe, Ok Hyun Park, et al.
Trends in Genetics (2020) Vol. 36, Iss. 3, pp. 177-188
Open Access | Times Cited: 344
Showing 1-25 of 344 citing articles:
The emerging role of RNA modifications in the regulation of mRNA stability
Sung Ho Boo, Yoon Ki Kim
Experimental & Molecular Medicine (2020) Vol. 52, Iss. 3, pp. 400-408
Open Access | Times Cited: 414
Sung Ho Boo, Yoon Ki Kim
Experimental & Molecular Medicine (2020) Vol. 52, Iss. 3, pp. 400-408
Open Access | Times Cited: 414
N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer
Zhenchuan Liu, Tingting Wang, Yunlang She, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 254
Zhenchuan Liu, Tingting Wang, Yunlang She, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 254
Quantitative profiling of pseudouridylation dynamics in native RNAs with nanopore sequencing
Oguzhan Begik, Morghan C. Lucas, Leszek P. Pryszcz, et al.
Nature Biotechnology (2021) Vol. 39, Iss. 10, pp. 1278-1291
Open Access | Times Cited: 241
Oguzhan Begik, Morghan C. Lucas, Leszek P. Pryszcz, et al.
Nature Biotechnology (2021) Vol. 39, Iss. 10, pp. 1278-1291
Open Access | Times Cited: 241
N6-methyladenosine-modified CircRNA-SORE sustains sorafenib resistance in hepatocellular carcinoma by regulating β-catenin signaling
Junjie Xu, Zhe Wan, Minyue Tang, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 226
Junjie Xu, Zhe Wan, Minyue Tang, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 226
Interaction between N6-methyladenosine (m6A) modification and noncoding RNAs in cancer
Yi Chen, Lin Yu, Yongqian Shu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 220
Yi Chen, Lin Yu, Yongqian Shu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 220
RNA modifications: importance in immune cell biology and related diseases
Lian Cui, Rui Ma, Jiangluyi Cai, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 194
Lian Cui, Rui Ma, Jiangluyi Cai, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 194
Quantitative sequencing using BID-seq uncovers abundant pseudouridines in mammalian mRNA at base resolution
Qing Dai, Lisheng Zhang, Hui‐Lung Sun, et al.
Nature Biotechnology (2022) Vol. 41, Iss. 3, pp. 344-354
Open Access | Times Cited: 159
Qing Dai, Lisheng Zhang, Hui‐Lung Sun, et al.
Nature Biotechnology (2022) Vol. 41, Iss. 3, pp. 344-354
Open Access | Times Cited: 159
Pooled CRISPR screening identifies m 6 A as a positive regulator of macrophage activation
Jiyu Tong, Xuefei Wang, Yongbo Liu, et al.
Science Advances (2021) Vol. 7, Iss. 18
Open Access | Times Cited: 151
Jiyu Tong, Xuefei Wang, Yongbo Liu, et al.
Science Advances (2021) Vol. 7, Iss. 18
Open Access | Times Cited: 151
Targeting the RNA m6A modification for cancer immunotherapy
Xinxin Li, Shoubao Ma, Youcai Deng, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 149
Xinxin Li, Shoubao Ma, Youcai Deng, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 149
M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma
Ashuai Du, Shiqin Li, Yuzheng Zhou, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 137
Ashuai Du, Shiqin Li, Yuzheng Zhou, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 137
YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner
Mengdie Feng, Xueqin Xie, Guoqiang Han, et al.
Blood (2021) Vol. 138, Iss. 1, pp. 71-85
Open Access | Times Cited: 133
Mengdie Feng, Xueqin Xie, Guoqiang Han, et al.
Blood (2021) Vol. 138, Iss. 1, pp. 71-85
Open Access | Times Cited: 133
Roles of RNA Methylation on Tumor Immunity and Clinical Implications
Maorun Zhang, Junmin Song, Weitang Yuan, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 126
Maorun Zhang, Junmin Song, Weitang Yuan, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 126
Hypoxia blocks ferroptosis of hepatocellular carcinoma via suppression of METTL14 triggered YTHDF2‐dependent silencing of SLC7A11
Zhuoyang Fan, Guowei Yang, Wei Zhang, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 21, pp. 10197-10212
Open Access | Times Cited: 120
Zhuoyang Fan, Guowei Yang, Wei Zhang, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 21, pp. 10197-10212
Open Access | Times Cited: 120
m6A reader YTHDC1 modulates autophagy by targeting SQSTM1 in diabetic skin
Diefei Liang, Wei‐Jye Lin, Meng Ren, et al.
Autophagy (2021) Vol. 18, Iss. 6, pp. 1318-1337
Open Access | Times Cited: 116
Diefei Liang, Wei‐Jye Lin, Meng Ren, et al.
Autophagy (2021) Vol. 18, Iss. 6, pp. 1318-1337
Open Access | Times Cited: 116
Transcriptome-wide profiling and quantification of N6-methyladenosine by enzyme-assisted adenosine deamination
Yu‐Lan Xiao, Shun Liu, Ruiqi Ge, et al.
Nature Biotechnology (2023) Vol. 41, Iss. 7, pp. 993-1003
Open Access | Times Cited: 106
Yu‐Lan Xiao, Shun Liu, Ruiqi Ge, et al.
Nature Biotechnology (2023) Vol. 41, Iss. 7, pp. 993-1003
Open Access | Times Cited: 106
The N6‐methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma
Li Liu, Jiangtu He, Guifeng Sun, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 5
Open Access | Times Cited: 101
Li Liu, Jiangtu He, Guifeng Sun, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 5
Open Access | Times Cited: 101
Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/β-catenin signaling to promote colorectal cancer progression by preventing m6A-mediated degradation of STEAP3 mRNA
Li Zhou, Jingwen Jiang, Zhao Huang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 100
Li Zhou, Jingwen Jiang, Zhao Huang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 100
Exon junction complex shapes the m6A epitranscriptome
Xin Yang, Robinson Triboulet, Qi Liu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 86
Xin Yang, Robinson Triboulet, Qi Liu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 86
RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner
Dan Yu, Min Pan, Yanshi Li, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 83
Dan Yu, Min Pan, Yanshi Li, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 83
Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance
Hong Lin, Di Wang, Pinghan Wang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 80
Hong Lin, Di Wang, Pinghan Wang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 80
PM2.5 induces pulmonary microvascular injury in COPD via METTL16-mediated m6A modification
Xiaolan Guo, Yuyin Lin, Yingnan Lin, et al.
Environmental Pollution (2022) Vol. 303, pp. 119115-119115
Closed Access | Times Cited: 71
Xiaolan Guo, Yuyin Lin, Yingnan Lin, et al.
Environmental Pollution (2022) Vol. 303, pp. 119115-119115
Closed Access | Times Cited: 71
N6-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma
Yuanlei Chen, Zeyi Lu, Chao Qi, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 71
Yuanlei Chen, Zeyi Lu, Chao Qi, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 71
The mechanism underlying redundant functions of the YTHDF proteins
Zhongyu Zou, Caraline Sepich‐Poore, Xiaoming Zhou, et al.
Genome biology (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 62
Zhongyu Zou, Caraline Sepich‐Poore, Xiaoming Zhou, et al.
Genome biology (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 62
N6-methyladenosine-mediated gene regulation and therapeutic implications
Yujiao Liu, Dan Yang, Tao Liu, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 6, pp. 454-467
Closed Access | Times Cited: 60
Yujiao Liu, Dan Yang, Tao Liu, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 6, pp. 454-467
Closed Access | Times Cited: 60
N6-methyladenosine reader YTHDF family in biological processes: Structures, roles, and mechanisms
Lin Chen, Yang Gao, Simiao Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 50
Lin Chen, Yang Gao, Simiao Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 50